Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort

M. Obón-Santacana, R. Kaaks, N. Slimani, L. Lujan-Barroso, H. Freisling, P. Ferrari, L. Dossus, N. Chabbert-Buffet, L. Baglietto, R. T. Fortner, H. Boeing, A. Tjønneland, A. Olsen, K. Overvad, V. Menéndez, E. Molina-Montes, N. Larrañaga, M. D. Chirlaque, E. Ardanaz, K. T. KhawN. Wareham, R. C. Travis, Y. Lu, M. A. Merritt, A. Trichopoulou, V. Benetou, D. Trichopoulos, C. Saieva, S. Sieri, R. Tumino, C. Sacerdote, R. Galasso, H. B. Bueno-De-Mesquita, E. Wirfält, U. Ericson, A. Idahl, N. Ohlson, G. Skeie, I. T. Gram, E. Weiderpass, N. C. Onland-Moret, E. Riboli, E. J. Duell

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Three prospective studies have evaluated the association between dietary acrylamide intake and endometrial cancer (EC) risk with inconsistent results. The objective of this study was to evaluate the association between acrylamide intake and EC risk: for overall EC, for type-I EC, and in never smokers and never users of oral contraceptives (OCs). Smoking is a source of acrylamide, and OC use is a protective factor for EC risk. Methods: Cox regression was used to estimate hazard ratios (HRs) for the association between acrylamide intake and EC risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Acrylamide intake was estimated from the EU acrylamide monitoring database, which was matched with EPIC questionnaire-based food consumption data. Acrylamide intake was energy adjusted using the residual method. Results: No associations were observed between acrylamide intake and overall EC (n=1382) or type-I EC risk (n=627). We observed increasing relative risks for type-I EC with increasing acrylamide intake among women who both never smoked and were non-users of OCs (HR Q5vsQ1: 1.97, 95% CI: 1.08-3.62; likelihood ratio test (LRT) P-value: 0.01, n=203). Conclusions: Dietary intake of acrylamide was not associated with overall or type-I EC risk; however, positive associations with type I were observed in women who were both non-users of OCs and never smokers.

Original languageEnglish
Pages (from-to)987-997
Number of pages11
JournalBritish Journal of Cancer
Volume111
Issue number5
DOIs
Publication statusPublished - 2014

Keywords

  • acrylamide
  • cohort
  • endometrial cancer
  • nutrition
  • type-I endometrial cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort'. Together they form a unique fingerprint.

Cite this